SECURITIES AMENDMENT AGREEMENTSecurities Amendment Agreement • September 24th, 2020 • Emmaus Life Sciences, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 24th, 2020 Company Industry JurisdictionTHIS SECURITIES AMENDMENT AGREEMENT (this “Agreement”), dated as of September 22, 2020, is entered into by and among EMI Holding, Inc, a Delaware corporation (the “Company”), Emmaus Life Sciences, Inc., a Delaware corporation and the parent company of EMI (“Emmaus”), and the parties identified as “Holders” on the signature page hereto (the “Holders”).